P. Chitano et al., THE EFFECTS OF TOLUENE DIISOCYANATE AND OF CAPSAICIN ON HUMAN BRONCHIAL SMOOTH-MUSCLE IN-VITRO, European journal of pharmacology. Environmental toxicology and pharmacology section, 270(2-3), 1994, pp. 167-173
Toluene diisocyanate contracts guinea-pig bronchial smooth muscle thro
ugh a mechanism involving capsaicin-sensitive sensory nerves. In the p
resent study, we investigated the effects of toluene diisocyanate, cap
saicin and tachykinins on isolated human bronchi. In 44 rings, toluene
diisocyanate (0.3 mM) produced a relaxation which averaged 16.9 +/- 1
.1%, in ten rings it produced a shortening that was 15.1 +/- 3.3% and
in ten preparations it gave no response. A second administration of to
luene diisocyanate (0.3 mM) always produced a relaxation (n = 13, 18.1
+/- 3.9%). Capsaicin (0.03 mM) produced shortening in 15 (35 +/- 6.6%
) and relaxation in 11 preparations (41 +/- 6.8%), whereas a second ad
ministration caused shortening in nine (25.1 +/- 6.1%) and relaxation
in 16 rings (36.4 +/- 4.9%). When toluene diisocyanate was given after
two consecutive capsaicin administrations, we observed shortening in
two rings (10.0 +/- 3.6%), relaxation in ten rings (15.9 +/- 3.6%), an
d no response in four preparations. To test the role of NK1 and NK2 re
ceptors in these conflicting responses, we performed concentration-res
ponse curves to different tachykinins. Substance P, neurokinin A and n
eurokinin A-(4-10), a specific NK2 receptor agonist, gave a concentrat
ion-dependent shortening, with neurokinin A being the most effective a
nd neurokinin A(4-10) the least. The specific NK1 receptor agonist, [S
ar(9),Met(O-2)(11)]substance P, produced both shortening and relaxatio
n. We conclude that toluene diisocyanate and capsaicin may produce bot
h shortening and relaxation in isolated human bronchi through NK1 rece
ptors.